Veterinary Medicines

DOG ECZEMA

Authorised
  • NEOMYCIN SULFATE
  • Prednisolone
  • PRECIPITATED SULPHUR
  • Zinc oxide
Download as PDF

Product identification

Medicine name:
ДОГ ЕКЗЕМА
DOG ECZEMA
Active substance:
  • NEOMYCIN SULFATE
  • Prednisolone
  • PRECIPITATED SULPHUR
  • Zinc oxide
Target species:
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    50000.00
    international unit(s)
    /
    100.00
    millilitre(s)
  • Prednisolone
    100.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • PRECIPITATED SULPHUR
    500.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Zinc oxide
    3.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Cutaneous emulsion
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD07CA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Farma Vet OOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Farmavet OOD
Responsible authority:
  • BFSA
Authorisation number:
  • 0022-2609
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 26/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."